For example, in pancreatic ductal adenocarcinoma (PDAC), an intraperitoneal injection of a SP100 derived RAGE antagonist peptide (RAP) inhibited tumor growth and metastasis via attenuation of ligand-dependent activation of NF-kB [65]. This evidence concerns the gene NFKB1 and pancreatic ductal adenocarcinoma.